PPRUY vs CPAY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PPRUY · KERING UNSPON ADR EA REPR 0.1 ORD EUR0.00$20.74 ▼ 2.35%
CPAY · Corpay$455.16 ▲ 1.83%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PPRUY -42.1%
- CPAY +61.9%
Head to head
| Metric | PPRUY | CPAY |
|---|---|---|
| Price | $20.74 | $455.16 |
| Change today | ▼ 2.35% | ▲ 1.83% |
| Market cap | $29.10B | $29.12B |
| Return, 3 months | -36.5% | +13.5% |
| Return, year to date | -40.6% | +51.3% |
| Return, 1 year | -40.2% | +64.6% |
| P/E (TTM) | – | 25.0 |
| P/B | 1.6 | 8.8 |
| P/E percentile vs own 5y | – | 91st |
| Dividend yield | 1.68% | – |
| Revenue growth (YoY, latest qtr) | – | +17.9% |
| Net profit growth (YoY) | – | +37.3% |
| Gross margin | – | 78.9% |
| Operating margin | – | 40.4% |
| Net margin | – | 23.7% |
| Return on equity | – | 33.7% |
| Analyst target vs. price | – | +8.5% |
| Analyst buy share | – | 75% |
| RSI (14) | 38 | 76 |
| 30-day volatility | 55.8% | 28.7% |
| Max drawdown, 1 year | -47.9% | -20.2% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CPAY is the largest of the group by market value.
- CPAY has returned the most over the past year.
- CPAY has been the calmest stock over the last 30 days.